Evado launches into Asia
Wednesday, 22 October, 2008
Melbourne company Evado has launched its clinical trial software into the growing south-east Asian market.
Evado is being distributed by local clinical research company SeerPharma.
Evado is a web-based mobile electronic data capture (EDC) system with two modules, one aimed at pre-clinical animal model trials and the other a clinical module for Phases I to IV.
It was developed in association with La Trobe University software researchers working at the university’s Microsoft Centre, along with Intel.
Evado CEO Jennie Anderson said the software was designed so that researchers can collect data on larger screens in a format similar to paper-based clinical research forms.
Next-gen therapies could treat high-grade gliomas
Government funding will enable researchers to test a suite of next-generation therapies they have...
Bacteriophage cocktail to combat superbugs
Entelli-02 is a five-phage cocktail designed specifically to target Enterobacter cloacae...
Exclusive colostrum intake may reduce risk of food allergies
Newborns who are exclusively fed colostrum in the first 72 hours following birth are five times...
